Copyright © 2013 AAHRPP ® All rights reserved Elyse I. Summers, J.D. President and CEO CAREB 2014 National Conference Montreal, Quebec April 23 – 26, 2014.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Ethics review and oversight for better governance of health research Amar Jesani Indian Journal of Medical Ethics Centre for Studies in Ethics and Rights.
Module 1 About University Research Responsibilities of PI and Research Staff Research at the University of Michigan PI and Research Staff Responsibilities.
Introduction to Human Subjects Research at the University of Michigan – Dearborn. Debra Schneider IRB Administrator (313)
AAHRPP Accreditation Siriraj Institutional Review Board (SIRB)
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
Welcome to Sterling IRB Our Total Commitment. Your Total Confidence
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
John Naim, PhD Director Clinical Trials Research Unit
Overview of AAHRPP Accreditation Process for NYU SoM (August 2007) Elan Czeisler IRB Director NYU School of Medicine INSTITUTIONAL REVIEW BOARD
Goals of Accreditation
Who Ultimately Protects Human Research Subjects? Presented by Bernard A Schwetz, D.V.M., Ph.D. Director Director Office for Human Research Protections.
How to Prevent Institutional Shutdowns: Safeguarding Your Human Subjects Research Program A Workshop Sponsored by the Experimental Biology 2005 Societies,
Basic Research Administration Principles Presented by Ronald Kiguba Research Coordinator, Makerere Medical School.
Overview of Good Clinical Practices (GCPs)
Chesapeake Research Review, Inc. Human Research Protection Experts IRB Services Consultation Education 1 Holding External IRBs Accountable: An Independent.
Copyright © 2013 AAHRPP ® All rights reserved Elyse I. Summers, J.D. President and CEO CAREB 2015 National Conference Vancouver, British Columbia May 1-2,
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Human Research Protection Program Institutional Review Board Requirements and Expectations of Researchers and Research Staff Moira A Keane, MA, CIP Executive.
Responsible Conduct of Research (RCR) Farida Lada October 16, 2013
UNM and Health System Internal Audit Departments Internal Audit Department Orientation Manu Patel, Internal Audit Director Purvi Mody, Executive Director,
CAREB ATLANTIC 2013 St. Thomas University and University of New Brunswick November 21st-22nd, 2013 Fredericton, NB Fredericton, NB.
A. Short term problems / considerations b. Long term mission View of human subjects protection system: SACHRP July 2008 Elizabeth Bankert.
Institutional Research Compliance Juliann Tenney, JD Research Compliance and Privacy Officer Director, Institutional Research Compliance Program.
Copyright © 2009 AAHRPP ® All rights reserved Update on AAHRPP – Revised Standards and Procedures Marjorie A. Speers, Ph.D. President and CEO.
Association for the Accreditation of Human Research Protection Programs (AAHRPP) Presentation/Discussion for IRB Members.
The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager.
© 2009 Cengage Learning. All Rights Reserved. Clinical Research.
Research Compliance: An Overview of the Players and Issues Involved in Emory’s Research Compliance Programs.
CCAS Annual Conference: New Orleans, LA November 11, 2010 The Role of Deans: Regulatory & Administrative Responsibilities Michelle Feige, MSW Public Health.
6/7/041 Seeking To Improve Human Research Protections through Accreditation John H. Mather MD Director, ORCR, OVPR.
Human Research Protection Program & IRB Responsibilities Marisue Cody, PhD Director Center on Advice & Compliance Help.
Improving Human Research Protections At MMC through Accreditation.
Institutional Review Board Issues for Classroom Research Sharon McWhorter IRB Administrator, The University of Akron (With assistance from Phil Allen,
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
Challenges of 21st Century Clinical Research from an Independent IRB’s View Chesapeake Research Review, Inc. Paul Goebel, CIP Vice President Matthew Whalen,
$100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 Terms Clinical Trial Facts.
Cloud security
Joni Barnard IRB Information Session: EHE Workshop 10/13/2015.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
High Level Symposium to Enhance Regulator Expertise on Good Regulatory Practices and the WTO Agreement on Technical Barriers to Trade.
GCP (GOOD CLINICAL PRACTISE)
HRPP METRICS Cynthia Monahan, MBA, CIP IRB Director Boston University Charles River Campus IRB.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
CLINICAL TRIALS.
Current Legal and Ethical Controversies in American Health Care
Research Compliance and Institutional Review Boards
How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
Brown Bag Series First Tuesday of each month (except July)
HUMAN RESEARCH PROTECTION PROGRAM or
AAHRPP Accreditation Welcome to the University of Georgia’s presentation for accreditation of the human research protection program (HRPP). This presentation.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
AAHRPP + IRB Update Michael Mahoney
Investigator Responsibilities: What should we expect from researchers?
Internal Controls Policies and Procedures
Elyse I. Summers, J.D. President and CEO
Presentation transcript:

Copyright © 2013 AAHRPP ® All rights reserved Elyse I. Summers, J.D. President and CEO CAREB 2014 National Conference Montreal, Quebec April 23 – 26, 2014

Outline  Who is AAHRPP? Que est AAHRPP?  What is AAHRPP’s role? Quel est le rôle de AAHRPP?  What we do/Ce que nous faisons  Questions/Questions

We are AAHRPP!!

AAHRPP Global non-profit organization founded in 2001 –Contract research organizations, hospitals, independent REBs/IRBs, research institutes, sponsors, universities and government agencies –Small (fewer than 20 protocols) and large (greater than 6,000 protocols) institutions –Clinical and non-clinical research programs –The world’s largest research-based pharmaceutical company

AAHRPP-Accredited organizations  As of March 2014, 196 organizations representing over 600 entities  Truly global – AAHRPP-accredited organizations in Canada, China, India, Korea, Mexico, Saudi Arabia, Singapore, Taiwan, United States  Other countries with organizations in the application process, include: Brazil, Belgium, Lebanon, Spain, Thailand

The focus of AAHRPP accreditation  Organization  REB or IRB  Researchers and Research staff Protecting research participants is a shared responsibility Human Research Protection Program }

Human Research Protection Program Organizational Plan Education Programs Conflict of Interest Researcher and Research Staff Compliance Oversight Communications System IRB or REB Pharmacy Services Contracts and Grants

AAHRPP Accreditation standards  Relevant Country laws, codes and guidelines  Based on ICH-GCP Guideline (E6)  If organization conducts research under U.S. federal regulations for conducting human research: U.S. Department of Health and Human Services (45 CFR part 46); U.S. Food and Drug Administration (21 CFR parts 50, 56)

AAHRPP Accreditation standards  Human Research Protection Program Domain 1: Organization Domain 2: REB or IRB Domain 3: Researchers and Research Staff

AAHRPP Accreditation standards AAHRPP process is outcomes-based approach  many possible avenues to achieve shared goal: Protection of the health and welfare of research volunteers, whose participation makes the whole enterprise possible.

What is accreditation of a human research protection program?  Accreditation of an Organization: –is voluntary –is flexible –is based on outcome-based standards consistent regulatory, legal, and ethical requirements allows a proportionate risk management approach –evaluates structures, processes, and outcomes –is not an audit of ethics decisions –is not an audit of individual studies –focuses on quality

Benefits of Accreditation  Assures highest level of protection afforded to participants  Increases public trust and participation in research  Meet uniform worldwide standards  Signals high standards of performance to sponsors  Facilitates collaborations across institutions

Benefits of Accreditation, cont’d.  Attract and retain high level researchers  Improves science – facilitates acceptance to prestigious journals  Fewer findings on FDA inspections  Fewer findings in OHRP compliance cases

AAHRPP’s Goals  One set of Standards Worldwide  Promote Organization-wide commitment to protecting participants in clinical research  Reinforce high standards and continuous quality improvement of HRPPs  Explore ways to improve efficiency 15

The AAHRPP Advantage: and Rigorous and Accessible HRPP Accreditation et Rigoureuse et accessible HRPP Accréditation

Oh, Canada Oh, Canada: Le moment est venu The time is right

Contact AAHRPP Elyse I. Summers, J.D. President and CEO Sarah Giannakopoulos Director of Operations Sarah Kiskaddon, J.D. Director of Global Business Development and Public Affairs